Drug Availability Update
Further to DrugAlert Volume 498, HPS Pharmacies wish to give notice that Aspen Pharmacare is continuing to experience a supply interruption for potassium chloride tablets as follows:
Normal supplies are now expected to resume in late May 2020. An internationally registered brand of potassium chloride 600mg sustained release tablets has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. Please note that Section 19A alternatives are subject to a longer lead time and different pricing as they must be sourced internationally.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Aspen Pharmacare on 1300 659 646.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates